\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\ significant\\ for\\ valgus\\ deformity\\ of\\ bilateral\\ knees\\,\\ right\\ \\>\\ left\\.\ \(0\)\
\-\ labs\\ significant\\ for\ \(0\)\
\-\ \\ 25\\ hydroxy\\ vitamin\\ d\\ 9\\ \\(less\\ than\\ 20\\ considered\\ abnormal\\)\ \(0\)\
\-\ \\ 1\\,25\\ dihydroxy\\ vitamin\\ d3\\ 20\\ \\(less\\ than\\ 27\\ abnormal\\)\ \(0\)\
\-\ \\ alkaline\\ phosphate\\ 2497\\ \\(normal\\ range\\ 38\\-126\\)\ \(1\)\
\-\ \\ pth\\ 404\\ \\(normal\\ range\\ 7\\-62\\)\ \(0\)\
\-\ the\\ patient\\ was\\ given\\ high\\ dose\\ vit\\ d\\ therapy\\ with\\ 600\\,000\\ iu\\ vit\\ d\\ po\\ in\\ divided\\ doses\\ as\\ an\\ inpatient\\ and\\ then\\ 400\\ iu\\ vit\\ d\\ po\\ qd\\.\\ \\ the\\ patient\\ was\\ given\\ 1000\\ mg\\ of\\ calcium\\ qd\\ as\\ hypocalcemia\\ can\\ be\\ an\\ adverse\\ reaction\\ of\\ supplemental\\ vit\\ d\\.\\ \\ further\\ follow\\ up\\ is\\ unknown\\.\ \(0\)\
\-\ please\\ see\\ image\\ captions\\ for\\ specific\\ findings\\ in\\ case\\ submitted\\.\\ \\ general\\ findings\\ include\\:\\ demineralization\\,\\ widening\\ of\\ the\\ epiphyseal\\ plates\\,\\ metaphyseal\\ cupping\\,\\ irregularity\\ and\\ indistinctness\\ of\\ the\\ provisional\\ zone\\ of\\ calcification\\,\\ poorly\\ ossified\\ epiphyses\\ with\\ indistinct\\ borders\\,\\ coarsened\\ trabeculae\\,\\ unsharp\\ border\\ of\\ the\\ inferior\\ scapular\\ angle\\ and\\ iliac\\ crest\\,\\ pathologic\\ fractures\\,\\ skeletal\\ deformities\\.\ \(0\)\
\-\ rickets\\ \\(vitamin\\ d\\ dependent\\)\ \(0\)\
\-\ abnormal\\ vit\\ d\\ metabolism\\ secondary\\ to\\:\ \(0\)\
\-\ vit\\ d\\ deficiency\\:\\ malabsorption\\,\\ inadequate\\ dietary\\ intake\\,\\ inadequate\\ sunlight\ \(0\)\
\-\ hepatic\\ origin\\:\\ anticonvulsant\\ therapy\\ \\(increased\\ hepatic\\ metabolism\\)\\,\\ liver\\ disease\\ \\(failure\\ of\\ 25\\ hydroxylation\\)\ \(1\)\
\-\ renal\\ origin\\:\\ vit\\ d\\ dependent\\ rickets\\,\\ parathyroid\\ disorders\\ \\(hypo\\,\\ hyper\\,\\ pseudohypo\\)\\,\\ maternal\\ renal\\ insufficiency\\ as\\ a\\ cause\\ of\\ congenital\\ rickets\\ and\\ secondary\\ hyperparathyroidism\\.\ \(0\)\
\-\ phosphate\\ loss\\ due\\ to\\ renal\\ tubular\\ disorders\\:\ \(0\)\
\-\ vit\\ d\\ resistant\\ rickets\\:\\ x\\-linked\\ hypophosphatemia\ \(0\)\
\-\ fanconi\\ syndrome\ \(0\)\
\-\ renal\\ tubular\\ acidosis\ \(5\)\
\-\ tumor\\ related\ \(0\)\
\-\ hemangiomas\\ of\\ the\\ bone\\ or\\ soft\\ tissue\ \(2\)\
\-\ metastatic\\ neuroblastoma\ \(2\)\
\-\ dietary\\ calcium\\ deficiency\ \(0\)\
\-\ 4\\ yo\\ female\\ with\\ inherited\\ vitamin\\ d\\-dependent\\ rickets\\.\\ \\ the\\ patients\\ mother\\ has\\ a\\ documented\\ history\\ of\\ rickets\\ as\\ well\\.\\ \\ the\\ patient\\ was\\ diagnosed\\ at\\ 30\\ months\\ of\\ age\\ after\\ presenting\\ to\\ her\\ primary\\ care\\ md\\ with\\ a\\ right\\ leg\\ limp\\.\\ \\ orthopedic\\ exam\\ and\\ subsequent\\ radiographs\\ and\\ labs\\ were\\ consistent\\ with\\ vitamin\\ d\\ dependent\\ rickets\\.\\ \\ the\\ patient\\ was\\ then\\ begun\\ on\\ supplemental\\ vit\\ d\\.\\ \\ however\\,\\ the\\ patient\\ had\\ poor\\ compliance\\ with\\ the\\ medication\\ and\\ follow\\ up\\.\\ \\ she\\ now\\ presented\\ because\\ her\\ father\\ was\\ concerned\\ she\\ may\\ need\\ surgery\\ for\\ her\\ worsening\\ valgus\\ deformity\\.\ \(0\)\
\-\ per\\ the\\ patients\\ record\\ she\\ had\\ the\\ diagnosis\\ of\\ hereditary\\ vit\\ d\\ dependent\\ rickets\\.\\ \\ however\\,\\ that\\ may\\ be\\ a\\ misdiagnosis\\ as\\ hereditary\\ vit\\ d\\ dependent\\ rickets\\ is\\ a\\ rare\\,\\ autosomal\\ recessive\\ disorder\\ that\\ typically\\ presents\\ as\\ early\\ as\\ 3\\ months\\ of\\ age\\,\\ in\\ contrast\\ to\\ nutritional\\ rickets\\,\\ with\\ most\\ patients\\ syptomatic\\ by\\ 1\\ year\\ of\\ age\\.\\ \\ furthermore\\,\\ rachitic\\ changes\\ can\\ be\\ severe\\ and\\ rapidly\\ progressive\\ with\\ pathologic\\ fractures\\.\\ \\ hypocalcemia\\ is\\ the\\ primary\\ rachitic\\ factor\\ from\\ decreased\\ intestinal\\ absorption\\ and\\ secondary\\ hypoparathyroidism\\ follows\\.\\ \\ this\\ patient\\ does\\ have\\ hypoparathyroidism\\,\\ as\\ evident\\ by\\ her\\ labs\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ vit\\:\\ 0\\.5357350441599786\ \(0\)\
\-\ rickets\\:\\ 0\\.39594148604547275\ \(0\)\
\-\ dependent\\:\\ 0\\.2076817644666131\ \(0\)\
\-\ vitamin\\:\\ 0\\.18845573994471732\ \(0\)\
\-\ as\\:\\ 0\\.1154159070260784\ \(0\)\
\-\ rachitic\\:\\ 0\\.10613374831443759\ \(0\)\
\-\ of\\:\\ 0\\.10541629391779173\ \(0\)\
\-\ hypocalcemia\\:\\ 0\\.10332416057646478\ \(0\)\
\-\ the\\:\\ 0\\.10031948410274544\ \(0\)\
\-\ hypoparathyroidism\\:\\ 0\\.09740637166545067\ \(0\)\
\-\ phosphate\\:\\ 0\\.09230118359612385\ \(0\)\
\-\ supplemental\\:\\ 0\\.09230118359612385\ \(0\)\
\-\ iu\\:\\ 0\\.09036028117124048\ \(0\)\
\-\ her\\:\\ 0\\.0897422722126438\ \(0\)\
\-\ renal\\:\\ 0\\.08945282206004067\ \(0\)\
\-\ dietary\\:\\ 0\\.08410967262687385\ \(0\)\
\-\ inadequate\\:\\ 0\\.08357380694713692\ \(0\)\
\-\ qd\\:\\ 0\\.08305981954051811\ \(0\)\
\-\ metabolism\\:\\ 0\\.08209080745747022\ \(0\)\
\-\ valgus\\:\\ 0\\.07995161836747681\ \(0\)\
\-\ 25\\:\\ 0\\.07632217827855432\ \(0\)\
\-\ labs\\:\\ 0\\.07463978346032195\ \(0\)\
\-\ hereditary\\:\\ 0\\.07383861712734927\ \(0\)\
\-\ po\\:\\ 0\\.073598782390002\ \(0\)\
\-\ deficiency\\:\\ 0\\.07027710790856011\ \(0\)\
\-\ patient\\:\\ 0\\.07008156133497444\ \(0\)\
\-\ age\\:\\ 0\\.06763708718225121\ \(0\)\
\-\ and\\:\\ 0\\.06678634404252273\ \(0\)\
\-\ calcium\\:\\ 0\\.06487140574101508\ \(0\)\
\-\ abnormal\\:\\ 0\\.06472573354492617\ \(0\)\
\-\ she\\:\\ 0\\.06413206700733837\ \(0\)\
\-\ secondary\\:\\ 0\\.06385723963462092\ \(0\)\
\-\ disorders\\:\\ 0\\.06341483006589743\ \(0\)\
\-\ was\\:\\ 0\\.06257784542458304\ \(0\)\
\-\ tubular\\:\\ 0\\.06239888058268985\ \(0\)\
\-\ origin\\:\\ 0\\.061826466421523556\ \(0\)\
\-\ patients\\:\\ 0\\.06060681843197173\ \(0\)\
\-\ pathologic\\:\\ 0\\.05885010878836732\ \(0\)\
\-\ deformity\\:\\ 0\\.05870370082463564\ \(0\)\
\-\ dihydroxy\\:\\ 0\\.05743056248171225\ \(0\)\
\-\ 2497\\:\\ 0\\.05743056248171225\ \(0\)\
\-\ unsharp\\:\\ 0\\.05743056248171225\ \(0\)\
\-\ syptomatic\\:\\ 0\\.05743056248171225\ \(0\)\
\-\ hepatic\\:\\ 0\\.0571964646710627\ \(0\)\
\-\ with\\:\\ 0\\.056255616068420417\ \(0\)\
\-\ range\\:\\ 0\\.05573500657760245\ \(0\)\
\-\ hydroxy\\:\\ 0\\.05487796844704885\ \(0\)\
\-\ hydroxylation\\:\\ 0\\.05487796844704885\ \(0\)\
\-\ fractures\\:\\ 0\\.053099089772536634\ \(0\)\
\-\ d3\\:\\ 0\\.053066874157218794\ \(0\)\
\-\ 404\\:\\ 0\\.053066874157218794\ \(0\)\
\-\ sunlight\\:\\ 0\\.053066874157218794\ \(0\)\
\-\ pseudohypo\\:\\ 0\\.053066874157218794\ \(0\)\
\-\ misdiagnosis\\:\\ 0\\.05166208028823239\ \(0\)\
\-\ then\\:\\ 0\\.050842410470664845\ \(0\)\
\-\ hypophosphatemia\\:\\ 0\\.050514280122555384\ \(0\)\
\-\ indistinctness\\:\\ 0\\.0495438289101137\ \(0\)\
\-\ given\\:\\ 0\\.049407145097493915\ \(0\)\
\-\ less\\:\\ 0\\.04886258701629925\ \(0\)\
\-\ coarsened\\:\\ 0\\.047961686087891975\ \(0\)\
\-\ captions\\:\\ 0\\.047298391963738924\ \(0\)\
\-\ provisional\\:\\ 0\\.047298391963738924\ \(0\)\
\-\ record\\:\\ 0\\.047298391963738924\ \(0\)\
\-\ anticonvulsant\\:\\ 0\\.046698369442574626\ \(0\)\
\-\ nutritional\\:\\ 0\\.046698369442574626\ \(0\)\
\-\ 20\\:\\ 0\\.04633595372566454\ \(0\)\
\-\ demineralization\\:\\ 0\\.04615059179806193\ \(0\)\
\-\ malabsorption\\:\\ 0\\.04615059179806193\ \(0\)\
\-\ compliance\\:\\ 0\\.04615059179806193\ \(0\)\
\-\ absorption\\:\\ 0\\.045646685212661554\ \(0\)\
\-\ inherited\\:\\ 0\\.04518014058562024\ \(0\)\
\-\ begun\\:\\ 0\\.04518014058562024\ \(0\)\
\-\ adverse\\:\\ 0\\.044745797929075515\ \(0\)\
\-\ doses\\:\\ 0\\.04433949750823187\ \(0\)\
\-\ cupping\\:\\ 0\\.04433949750823187\ \(0\)\
\-\ epiphyses\\:\\ 0\\.04433949750823187\ \(0\)\
\-\ crest\\:\\ 0\\.04433949750823187\ \(0\)\
\-\ primary\\:\\ 0\\.04416359362466274\ \(0\)\
\-\ be\\:\\ 0\\.04370377449055488\ \(0\)\
\-\ for\\:\\ 0\\.04353819425616744\ \(0\)\
\-\ trabeculae\\:\\ 0\\.0432576191124974\ \(0\)\
\-\ scapular\\:\\ 0\\.0432576191124974\ \(0\)\
\-\ 1000\\:\\ 0\\.04293470363924547\ \(0\)\
\-\ pth\\:\\ 0\\.04262754655095683\ \(0\)\
\-\ 400\\:\\ 0\\.04262754655095683\ \(0\)\
\-\ however\\:\\ 0\\.04251100805904327\ \(0\)\
\-\ plates\\:\\ 0\\.04205483631343693\ \(0\)\
\-\ concerned\\:\\ 0\\.04205483631343693\ \(0\)\
\-\ months\\:\\ 0\\.041806983153286285\ \(0\)\
\-\ ossified\\:\\ 0\\.04178690347356846\ \(0\)\
\-\ limp\\:\\ 0\\.04178690347356846\ \(0\)\
\-\ recessive\\:\\ 0\\.04178690347356846\ \(0\)\
\-\ resistant\\:\\ 0\\.041529909770259055\ \(0\)\
\-\ significant\\:\\ 0\\.04146920287517404\ \(0\)\
\-\ indistinct\\:\\ 0\\.0412829968881681\ \(0\)\
\-\ therapy\\:\\ 0\\.041267155690372204\ \(0\)\
\-\ hypo\\:\\ 0\\.04104540372873511\ \(0\)\
\-\ acidosis\\:\\ 0\\.040816452261126776\ \(0\)\
\-\ than\\:\\ 0\\.04071459818859124\ \(0\)\
\-\ alkaline\\:\\ 0\\.04038210960458206\ \(0\)\
\-\ divided\\:\\ 0\\.03997580918373841\ \(0\)\
\-\ epiphyseal\\:\\ 0\\.03978208708341775\ \(0\)\
\-\ parathyroid\\:\\ 0\\.03941165839214037\ \(0\)\
\-\ intake\\:\\ 0\\.03923430943890506\ \(0\)\
\-\ maternal\\:\\ 0\\.03923430943890506\ \(0\)\
\-\ furthermore\\:\\ 0\\.0390618199776175\ \(0\)\
\-\ hyper\\:\\ 0\\.03889393078800393\ \(0\)\
\-\ follow\\:\\ 0\\.03871900648794252\ \(0\)\
\-\ inpatient\\:\\ 0\\.038571015314752\ \(0\)\
\-\ documented\\:\\ 0\\.038415563675787245\ \(0\)\
\-\ father\\:\\ 0\\.03826385822646337\ \(0\)\
\-\ submitted\\:\\ 0\\.037970992793587705\ \(0\)\
\-\ metaphyseal\\:\\ 0\\.03769114798894346\ \(0\)\
\-\ can\\:\\ 0\\.03769060305415333\ \(0\)\
\-\ knees\\:\\ 0\\.037423215149075\ \(0\)\
\-\ autosomal\\:\\ 0\\.03704155456988387\ \(0\)\
\-\ deformities\\:\\ 0\\.03645276393663331\ \(0\)\
\-\ intestinal\\:\\ 0\\.03634133675334053\ \(0\)\
\-\ may\\:\\ 0\\.03614375945733498\ \(0\)\
\-\ borders\\:\\ 0\\.03612423001454283\ \(0\)\
\-\ rapidly\\:\\ 0\\.03591436153064511\ \(0\)\
\-\ to\\:\\ 0\\.035911377928962256\ \(0\)\
\-\ had\\:\\ 0\\.035785018865643725\ \(0\)\
\-\ up\\:\\ 0\\.03552829009538037\ \(0\)\
\-\ findings\\:\\ 0\\.03544768936190139\ \(0\)\
\-\ follows\\:\\ 0\\.035138553954280054\ \(0\)\
\-\ irregularity\\:\\ 0\\.03478378564795809\ \(0\)\
\-\ zone\\:\\ 0\\.034698131653124034\ \(0\)\
\-\ insufficiency\\:\\ 0\\.03461362741110219\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.03420732699025854\ \(0\)\
\-\ factor\\:\\ 0\\.03367925349799954\ \(0\)\
\-\ dose\\:\\ 0\\.03353616844096566\ \(0\)\
\-\ medication\\:\\ 0\\.033192067962285\ \(0\)\
\-\ widening\\:\\ 0\\.033125448594524064\ \(0\)\
\-\ iliac\\:\\ 0\\.03305952682458154\ \(0\)\
\-\ need\\:\\ 0\\.03305952682458154\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.03299428819407929\ \(0\)\
\-\ md\\:\\ 0\\.03273989109691341\ \(0\)\
\-\ skeletal\\:\\ 0\\.03255562023918117\ \(0\)\
\-\ poorly\\:\\ 0\\.03243570287050754\ \(0\)\
\-\ orthopedic\\:\\ 0\\.031868159208169475\ \(0\)\
\-\ border\\:\\ 0\\.031760541690049375\ \(0\)\
\-\ angle\\:\\ 0\\.03149928131663037\ \(0\)\
\-\ mg\\:\\ 0\\.0313475758673065\ \(0\)\
\-\ that\\:\\ 0\\.031168627475400685\ \(0\)\
\-\ evident\\:\\ 0\\.03086677195556035\ \(0\)\
\-\ mother\\:\\ 0\\.030684281743153442\ \(0\)\
\-\ reaction\\:\\ 0\\.030550803849030462\ \(0\)\
\-\ by\\:\\ 0\\.030500347317483124\ \(0\)\
\-\ disorder\\:\\ 0\\.030377124654864807\ \(0\)\
\-\ poor\\:\\ 0\\.030292049420914242\ \(0\)\
\-\ please\\:\\ 0\\.030125272210726996\ \(0\)\
\-\ per\\:\\ 0\\.0298044144173449\ \(0\)\
\-\ pe\\:\\ 0\\.02968818702680032\ \(0\)\
\-\ is\\:\\ 0\\.02950395630256692\ \(0\)\
\-\ normal\\:\\ 0\\.02932498003780176\ \(0\)\
\-\ 27\\:\\ 0\\.02910213892093172\ \(0\)\
\-\ general\\:\\ 0\\.028828379637791543\ \(0\)\
\-\ presenting\\:\\ 0\\.02813168770849004\ \(0\)\
\-\ considered\\:\\ 0\\.027983552132528462\ \(0\)\
\-\ progressive\\:\\ 0\\.027504470883676017\ \(0\)\
\-\ an\\:\\ 0\\.027464996548320894\ \(0\)\
\-\ worsening\\:\\ 0\\.02742358576880513\ \(0\)\
\-\ related\\:\\ 0\\.02729104463110167\ \(0\)\
\-\ failure\\:\\ 0\\.02726486799669021\ \(0\)\
\-\ unknown\\:\\ 0\\.02721283901042137\ \(0\)\
\-\ specific\\:\\ 0\\.02721283901042137\ \(0\)\
\-\ subsequent\\:\\ 0\\.027186984881658185\ \(0\)\
\-\ leg\\:\\ 0\\.027110053518953237\ \(0\)\
\-\ rare\\:\\ 0\\.027110053518953237\ \(0\)\
\-\ in\\:\\ 0\\.02680096665087819\ \(0\)\
\-\ diagnosed\\:\\ 0\\.026013436330371342\ \(0\)\
\-\ early\\:\\ 0\\.02588625076211526\ \(0\)\
\-\ congenital\\:\\ 0\\.02580286581452355\ \(0\)\
\-\ care\\:\\ 0\\.025659548078780077\ \(0\)\
\-\ calcification\\:\\ 0\\.0256393378800243\ \(0\)\
\-\ typically\\:\\ 0\\.025210378269130973\ \(0\)\
\-\ because\\:\\ 0\\.02509828976208048\ \(0\)\
\-\ does\\:\\ 0\\.024826500584262508\ \(0\)\
\-\ liver\\:\\ 0\\.024773522951804256\ \(0\)\
\-\ now\\:\\ 0\\.02465161512998476\ \(0\)\
\-\ 30\\:\\ 0\\.024498267240916183\ \(0\)\
\-\ cause\\:\\ 0\\.024464691313298075\ \(0\)\
\-\ inferior\\:\\ 0\\.024431293508149626\ \(0\)\
\-\ right\\:\\ 0\\.02381240239239835\ \(0\)\
\-\ further\\:\\ 0\\.023389866667887806\ \(0\)\
\-\ radiographs\\:\\ 0\\.02329182619809786\ \(0\)\
\-\ image\\:\\ 0\\.022966826476687262\ \(0\)\
\-\ severe\\:\\ 0\\.022733634206287552\ \(0\)\
\-\ yo\\:\\ 0\\.02243556805316095\ \(0\)\
\-\ see\\:\\ 0\\.02233926833215694\ \(0\)\
\-\ decreased\\:\\ 0\\.022244419509715577\ \(0\)\
\-\ loss\\:\\ 0\\.021878699473486217\ \(0\)\
\-\ changes\\:\\ 0\\.021703509831369906\ \(0\)\
\-\ syndrome\\:\\ 0\\.02164974800587788\ \(0\)\
\-\ include\\:\\ 0\\.02136711079865704\ \(0\)\
\-\ presented\\:\\ 0\\.020941646066192983\ \(0\)\
\-\ due\\:\\ 0\\.020642695111813263\ \(0\)\
\-\ high\\:\\ 0\\.020409834627310792\ \(0\)\
\-\ bone\\:\\ 0\\.019594521041737846\ \(0\)\
\-\ consistent\\:\\ 0\\.01947212648910971\ \(0\)\
\-\ increased\\:\\ 0\\.01941931815005586\ \(0\)\
\-\ surgery\\:\\ 0\\.019307627375936498\ \(0\)\
\-\ bilateral\\:\\ 0\\.019300251310059628\ \(0\)\
\-\ soft\\:\\ 0\\.019118603639343715\ \(0\)\
\-\ tissue\\:\\ 0\\.01883844744746035\ \(0\)\
\-\ tumor\\:\\ 0\\.018783881805703187\ \(0\)\
\-\ most\\:\\ 0\\.018689515369580214\ \(0\)\
\-\ diagnosis\\:\\ 0\\.01861635005946833\ \(0\)\
\-\ were\\:\\ 0\\.018511423105463144\ \(0\)\
\-\ exam\\:\\ 0\\.01807794765348013\ \(0\)\
\-\ case\\:\\ 0\\.01804162752482222\ \(0\)\
\-\ have\\:\\ 0\\.017939844028040743\ \(0\)\
\-\ contrast\\:\\ 0\\.01744874241597561\ \(0\)\
\-\ after\\:\\ 0\\.0174213350087099\ \(0\)\
\-\ well\\:\\ 0\\.017388602847421497\ \(0\)\
\-\ female\\:\\ 0\\.017329032349984244\ \(0\)\
\-\ presents\\:\\ 0\\.01727536219112014\ \(0\)\
\-\ has\\:\\ 0\\.016403399952999276\ \(0\)\
\-\ disease\\:\\ 0\\.015074439135956366\ \(0\)\
\-\ from\\:\\ 0\\.014262588893151299\ \(0\)\
\-\ history\\:\\ 0\\.013720333108045091\ \(0\)\
\-\ at\\:\\ 0\\.01356428864724217\ \(0\)\
\-\ or\\:\\ 0\\.012493027090053618\ \(0\)\
\-\ this\\:\\ 0\\.012339893124384667\ \(0\)\
\-\ left\\:\\ 0\\.012250250491560475\ \(0\)\
\-\ year\\:\\ 0\\.011067266600843745\ \(0\)\
\-\ on\\:\\ 0\\.010845937762205602\ \(0\)\
